617 Works

Illicit use of prescription cognitive enhancing (CE) drugs among regular psychostimulant users

Marina Nelson & Simon Lenton
EDRS Drug Trends Bulletin, July 2017

Evaluation of the Youth Advocate Program

J Skattebol & H Blunden

ASELCC Research Synthesis Report

S Gendera & I Katz

Australian Drug Trends 2019: Key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews

A Peacock, T Karlsson, J Uporova, D Gibbs, R Swanton, G Kelly, O Price, R Bruno, P Dietze, S Lenton, C Salom, L Degenhardt & M Farrell

Human Rights protection frameworks for people being treated involuntarily for a mental illness: Literature review

S Gendera, G Giuntoli, KR Fisher & R Kayess

Annual Report of Trends in Behaviour 2019: HIV and STIs in Australia

L Mao, M Holt, C Newman & C Treloar

Evaluation of the Keeping Women Safe – Private Rental Initiative

H Blunden, K valentine & P Jops

Self-report and serological HCV status amongst people who inject drugs in NSW and ACT

D Gibbs, J Grebely, S Larney, K Butler, R Sutherland, M Starr, A Karlsson, J Uporova, L Degenhardt, M Farrell & A Peacock

Establishing a Child Development Fund in Australia: A review of international models

H Blunden & I Katz

Understanding barriers to STI testing among young people: results from the online survey ‘Getting Down to it'

PCG Adam, JBF de Wit, J Herman, L Story, B Edwards, C Murray & C Bourne

The 2018 Australian Trans and Gender Diverse Sexual Health Survey: Report of Findings

Denton Callander, Vincent Cornelisse, Martin Holt & James MacGibbon

Stories of educational engagement among young people with complex families: A snapshot from the Stories of Resourcing and Resourcefulness project

M Blaxland, J Skattebol, C Thomson, M Hamilton & K valentine

Financial security and the influence of economic resources

M Weier, A Marjolin, A Powell & K Muir

Background report on young people’s economic engagement

A Powell, F Salignac, A Meltzer, K Muir & M Weier

Monograph No. 26: Reducing stigma and discrimination for people experiencing problematic alcohol and other drug use

K Lancaster, K Seear & A Ritter

Rural landholder engagement under the NSW Land Management (Native Vegetation) Code 2018: Social aspects and impact: One year on

S Bates, T Broady & L Mao

Trends in drug-induced deaths in Australia, 1997-2018

N Man, A Chrzanowska, T Dobbins, L Degenhardt & A Peacock

Trends in HIV and HIV prevention indicators in gay, bisexual and other men who have sex with men in NSW, 2015-2019: implications for new interventions and for monitoring and evaluation in a new NSW HIV strategy

A Grulich, S Nigro, C Chan, P Patel, B Bavinton, M Holt, G Prestage, D Callander, C Murray, C Power, A Pinto, L Mao, T Broady & P Keen

Barriers and enablers associated with access and equity in alcohol and other drug treatment in NSW

J Bryant, R Horwitz, R Gray, L Lafferty, P Jops, H Blunden & L Brener

Have COVID-19 restrictions affected needle and syringe program transactions in Tasmania?

R Bruno, T Wilson & M Griggs

Engagement in drug checking (‘pill testing’) and behavioural responses among a sample of people who regularly use drugs in New South Wales

D Gibbs & A Peacock

Drug driving laws in Australia: What are they and why do they matter?

V Moxham-Hall & C Hughes

The involvement of Kynurenine pathway in multiple sclerosis mice model

Gayathri Sundaram
Multiple sclerosis (MS) is a demyelinating disease of central nervous system caused by unknown multi-faceted disease inducing factors. Experimental autoimmune encephalomyelitis (EAE), an animal model for MS, manifests various forms that parallel several aspects of MS. Kynurenine pathway is the major pathway for tryptophan metabolism producing number of catabolites along its route having neurotoxic [quinolinic acid (QUIN)] and neuroprotective [kynurenic acid (KYNA) and picolinic acid (PIC)] properties. Kynurenine pathway is thought to be involved in...

Registration Year

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Resource Types

  • Text